• Publications
  • Influence
Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.
Arrhythmia-induced cardiomyopathy (AIC) is a potentially reversible condition in which left ventricular dysfunction is induced or mediated by atrial or ventricular arrhythmias. Cellular andExpand
  • 131
  • 16
  • PDF
Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis
Aims Left atrial (LA) diameter is a predictor of atrial fibrillation (AF) recurrence following radiofrequency catheter ablation (RFA). However, LA volume (LAV) is more accurate in assessing LA size.Expand
  • 42
  • 2
Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
An increasing number of individuals are on novel oral anticoagulants (NOAC) for anticoagulation instead of vitamin K antagonists (VKA) and roughly 10% of these individuals will require interruptionExpand
  • 23
  • 1
  • PDF
Tachycardia-mediated cardiomyopathy: Recognition and management
Tachycardia-mediated cardiomyopathy is a cause of ventricular dysfunction due to, at least partially, persistent tachycardia leading to cellular and extracellular perturbations. Cardiomyopathy mayExpand
  • 27
  • 1
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the
Abstract Covid-19 is a global pandemic that is wreaking havoc with the health and economy of much of human civilization. Electrophysiologists have been impacted personally and professionally byExpand
  • 25
  • 1
Cardiac Arrhythmias in COVID-19 Infection
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19, has affected >1 million people worldwide.1 As of this writing, >60 000 people have died as a result ofExpand
  • 22
  • 1
Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients
Background Many patients with heart failure continue cardiac resynchronization therapy (CRT) after continuous flow left ventricular assist device (CF‐LVAD) implant. We report the first multicenterExpand
  • 9
  • 1
  • PDF
Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.
BACKGROUND Percutaneous left atrial appendage exclusion (LAAE) has evolved as an alternative strategy for stroke prevention in atrial fibrillation (AF). Recent observational data have suggested thatExpand
  • 8
  • 1
COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies
Background Cardiovascular and arrhythmic events have been reported in hospitalized COVID-19 patients. However, arrhythmia manifestations and treatment strategies used in these patients have not beenExpand
  • 16
  • 1
Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times
Atrial fibrillation (AF) and heart failure (HF) are growing cardiovascular disease epidemics worldwide. There has been an exponential increase in the prevalence of AF and HF correlating with anExpand
  • 15
  • 1
  • PDF